Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TELEFLEX INCORPORATED

(TFX)
  Report
Real-time Estimate Cboe BZX  -  01:16 2022-10-04 pm EDT
204.87 USD   -1.74%
09/28Teleflex launches new Arrow Pressure Injectable Midline Catheter Portfolio
AQ
09/28Teleflex Completes Acquisition of Standard Bariatrics
MT
09/28Teleflex Completes Acquisition of Standard Bariatrics
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Teleflex Incorporated : Teleflex Acquires Innovative Technology for Laryngeal Masks and other Airway Management Devices

06/11/2013 | 07:35pm EDT

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, today announced it has acquired the assets of Ultimate Medical and its affiliates. Ultimate Medical is a leading supplier and innovator of airway management devices with a portfolio of patented products and a full range of laryngeal mask airways.

Ultimate Medical developed the Cuff PilotTM, the world's first integrated cuff pressure indicator for single-use airway management devices. This novel technology is a single-use device and it provides constant inside-the-cuff pressure indication, allowing for at-a-glance clinical assessments.

The Cuff Pilot technology is currently used with Ultimate Medical's portfolio of laryngeal masks and has potential application for use with Teleflex's market leading brand of LMATM laryngeal masks.

Teleflex has had a development partnership with Ultimate Medical since April 2010 related to the integration of cuff pressure technology into some products and currently distributes Ultimate's portfolio of laryngeal masks in select international markets.

In addition to the Cuff Pilot technology, the acquisition of Ultimate Medical further supports Teleflex's strategy to grow global supraglottic airway procedural usage by expanding their LMATM portfolio to include a full range of silicone laryngeal masks and other complimentary products. The transaction also brings innovative technologies and intellectual property that is expected to bring value to Teleflex outside of the airway management device portfolio.

"We consider the acquisition of Ultimate Medical to be a perfect match," said Liam Kelly, Executive Vice President, President, International. Added Kelly, "The acquisition of Ultimate Medical was a logical step after we acquired The Laryngeal Mask Company and its affiliates last year. This acquisition provides Teleflex with additional innovative, and cost-effective, airway management options for our customers and underscores our commitment to leadership in airway management medical devices."

The financial terms of the acquisition were not disclosed.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,700 people worldwide and serves healthcare providers in more than 140 countries. For additional information about Teleflex please refer to www.teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836


© Business Wire 2013
All news about TELEFLEX INCORPORATED
09/28Teleflex launches new Arrow Pressure Injectable Midline Catheter Portfolio
AQ
09/28Teleflex Completes Acquisition of Standard Bariatrics
MT
09/28Teleflex Completes Acquisition of Standard Bariatrics
GL
09/28Teleflex Completes Acquisition of Standard Bariatrics
AQ
09/28Teleflex Incorporated completed the acquisition of Standard Bariatrics, Inc.
CI
09/27Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio
GL
09/27Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio
AQ
09/27Teleflex Incorporated Launches New Arrow® Pressure Injectable Midline Catheter Portfoli..
CI
09/22Truist Securities Lowers Teleflex's Price Target to $241 From $265, Maintains Hold Rati..
MT
09/21Predicting The Unpredictable – When Is A Combination Obvious?
AQ
More news
Analyst Recommendations on TELEFLEX INCORPORATED
More recommendations
Financials (USD)
Sales 2022 2 809 M - -
Net income 2022 409 M - -
Net Debt 2022 1 060 M - -
P/E ratio 2022 24,1x
Yield 2022 0,65%
Capitalization 9 779 M 9 779 M -
EV / Sales 2022 3,86x
EV / Sales 2023 3,48x
Nbr of Employees 14 000
Free-Float 97,6%
Chart TELEFLEX INCORPORATED
Duration : Period :
Teleflex Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELEFLEX INCORPORATED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 208,50 $
Average target price 275,82 $
Spread / Average Target 32,3%
EPS Revisions
Managers and Directors
Liam J. Kelly Chairman, President & Chief Executive Officer
Thomas E. Powell Chief Financial Officer & Executive Vice President
Timothy F. Duffy Chief Information Officer & Vice President
Michelle Fox Chief Medical Officer & Vice President
Justin McMurray VP-Global Strategic Research & Development
Sector and Competitors
1st jan.Capi. (M$)
TELEFLEX INCORPORATED-36.53%9 779
ABBOTT LABORATORIES-29.29%174 281
MEDTRONIC PLC-20.06%109 921
BECTON, DICKINSON AND COMPANY-6.10%65 817
HOYA CORPORATION-18.82%34 410
DEXCOM, INC.-36.69%33 362